Leyman Barbara has filed 7 insider transactions across 1 company since July 2024.
Most recent transaction: a tax payment of 8944 shares of SUTRO BIOPHARMA, INC. ($STRO) on July 08, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 8, 2025 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Officer | F | Common Stock | 8944 | $0.78 | 16,056.0000 | 83,775,336 | 35.78% | 0.01% |
| July 8, 2025 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Officer | M | Restricted Stock Units (RSUs) | 25000 | $0.00 | 75,000.0000 | 83,775,336 | 25.00% | 0.03% |
| July 8, 2025 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Officer | M | Common Stock | 25000 | $0.00 | 25,000.0000 | 83,775,336 | 9999.99% | 0.03% |
| April 4, 2025 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Dev. Officer | A | Restricted Stock Units (RSUs) | 84500 | $0.00 | 84,500.0000 | 83,775,336 | 9999.99% | 0.10% |
| April 4, 2025 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Dev. Officer | A | Stock Option (Right to Buy) | 91000 | $0.00 | 91,000.0000 | 83,775,336 | 9999.99% | 0.11% |
| July 8, 2024 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Dev. Officer | A | Restricted Stock Units (RSUs) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| July 8, 2024 | SUTRO BIOPHARMA, INC. | $STRO | Leyman Barbara | Chief Business Dev. Officer | A | Stock Option (Right to Buy Common Stock) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |